Transcription-independent pro-apoptotic functions of p53

Current Opinion in Cell Biology

Volumn 17, Issue 6, 2005, Pages 631-636

  Moll, Ute M ^a   Wolff, Sonja ^a   Speidel, Daniel ^b   Deppert, Wolfgang ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN P53;

APOPTOSIS; CELL STRAIN 3T3; CYTOSOL; DNA DAMAGE; ENZYME ACTIVATION; GAMMA IRRADIATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; MITOCHONDRION; NONHUMAN; OLIGOMERIZATION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; ULTRAVIOLET IRRADIATION;

APOPTOSIS; CYTOSOL; HUMANS; MITOCHONDRIAL PROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 27544486327     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2005.09.007     Document Type: Review

References (41)

1. D.P. Lane Cancer. p53, guardian of the genome Nature 358 1992 15 16
2. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
3. J.S. Fridman, and S.W. Lowe Control of apoptosis by p53 Oncogene 22 2003 9030 9040
4. K.H. Vousden, and X. Lu Live or let die: the cell's response to p53 Nat Rev Cancer 2 2002 594 604
5. C. Caelles, A. Helmberg, and M. Karin p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes Nature 370 1994 220 223
6. A.J. Wagner, J.M. Kokontis, and N. Hay Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1 Genes Dev 8 1994 2817 2830
7. Y. Haupt, S. Rowan, E. Shaulian, K.H. Vousden, and M. Oren Induction of apoptosis in HeLa cells by trans-activation-deficient p53 Genes Dev 9 1995 2170 2183
8. X. Chen, L.J. Ko, L. Jayaraman, and C. Prives p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells Genes Dev 10 1996 2438 2451
9. N.D. Marchenko, A. Zaika, and U.M. Moll Death signal-induced localization of p53 protein to mitochondria: a potential role in apoptotic signaling J Biol Chem 275 2000 16202 16212
10. C. Sansome, A. Zaika, N.D. Marchenko, and U.M. Moll Hypoxia death stimulus induces translocation of p53 protein to mitochondria: detection by immunofluorescence on whole cells FEBS Lett 488 2001 110 115
11. M. Mihara, S. Erster, A. Zaika, O. Petrenko, T. Chittenden, P. Pancoska, and U.M. Moll p53 has a direct apoptogenic role at the mitochondria Mol Cell 11 2003 577 590 The first demonstration that p53 directly induces permeabilization of the outer mitochondrial membrane by forming complexes with the protective Bcl-xL and Bcl-2 proteins. The p53 DNA binding domain of p53 and the BH4 domain of Bcl-xL interact. Conversely, tumor-derived transactivation-deficient point mutants of p53 concomitantly lose the ability to interact with Bcl-xL and to promote cytochrome c release. The authors propose that mutations might represent 'double-hits' by abrogating the transcriptional and mitochondrial apoptotic activity of p53.
12. P. Dumont, J.I. Leu, A.C. Della Pietra III, D.L. George, and M. Murphy The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat Genet 33 2003 357 365 The authors show that codon 72 Arg/Pro polymorphic variants of p53 differ in their ability to induce apoptosis. The Arg72 variant has a greater apoptotic potential than the Pro72 variant, and this enhanced ability to induce apoptosis correlates with an increased mitochondrial translocation of the p53 Arg72 variant. When the Pro72 variant is forced to mitochondria, the differences disappear.
13. J.I. Leu, P. Dumont, M. Hafey, M.E. Murphy, and D.L. George Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex Nat Cell Biol 6 2004 443 450 This paper shows that mitochondrial p53 and the anti-apoptotic mitochondrial Bcl-2 family member Mcl-1 have opposing effects on mitochondrial apoptosis by directly interacting with and modulating the activity of the death effector Bak. Interaction of p53 with Bak causes oligomerization of Bak and release of cytochrome c from mitochondria.
14. S. Erster, M. Mihara, R.H. Kim, O. Petrenko, and U.M. Moll In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation Mol Cell Biol 24 2004 6728 6741 The paper characterizes the mitochondrial p53 response in vivo. In irradiated mice, mitochondrial p53 accumulation occurs in radiosensitive organs but not in radioresistant organs. p53 translocation is rapid (30 min) and triggers an early wave of marked caspase 3 activation and apoptosis which precedes the transcriptional p53 program, which has a longer lag phase. Target gene induction (Puma being the fastest) then leads to further increase in active caspase 3.
15. Y. Arima, M. Nitta, S. Kuninaka, D. Zhang, T. Fujiwara, Y. Taya, M. Nakao, and H. Saya Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria J Biol Chem 280 2005 19166 19176
16. A. Nemajerova, S. Erster, and U.M. Moll The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria Cell Death Differ 12 2005 197 200
17. M. Bonafe, S. Salvioli, C. Barbi, C. Trapassi, F. Tocco, G. Storci, L. Invidia, I. Vannini, M. Rossi, and E. Marzi The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death Cell Death Differ 11 2004 962 973
18. H. Yamaguchi, J. Chen, K. Bhalla, and H.G. Wang Regulation of Bax activation and apoptotic response to microtubule-damaging agents by p53 transcription-dependent and -independent pathways J Biol Chem 279 2004 39431 39437
19. Y. Zhao, L. Chaiswing, J.M. Velez, I. Batinic-Haberle, N.H. Colburn, T.D. Oberley, and D.K. St Clair p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase Cancer Res 65 2005 3745 3750
20. B.S. Park, Y.S. Song, S.B. Yee, B.G. Lee, S.Y. Seo, Y.C. Park, J.M. Kim, H.M. Kim, and Y.H. Yoo Phospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosis Apoptosis 10 2005 193 200
21. J.E. Chipuk, T. Kuwana, L. Bouchier-Hayes, N.M. Droin, D.D. Newmeyer, M. Schuler, and D.R. Green Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis Science 303 2004 1010 1014 By elegant in vitro assays, this paper provides compelling evidence that cytosolic p53 has the capacity to directly activate Bax without the requirement of other factors or active transcription.
22. A.M. Petros, A. Gunasekera, N. Xu, E.T. Olejniczak, and S.W. Fesik Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR FEBS Lett 559 2004 171 174 A nuclear magnetic resonance study confirming that the Bcl-xL interaction surface on p53 involves the DNA-binding region of p53. The binding site on Bcl-xL involves the BH4 domain and loops between α 3-4 and 5-6.
23. C.A. Midgley, B. Owens, C.V. Briscoe, D.B. Thomas, D.P. Lane, and P.A. Hall Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo J Cell Sci 108 1995 1843 1848
24. D.E. MacCallum, T.R. Hupp, C.A. Midgley, D. Stuart, S.J. Campbell, A. Harper, F.S. Walsh, E.G. Wright, A. Balmain, and D.P. Lane The p53 response to ionising radiation in adult and developing murine tissues Oncogene 13 1996 2575 2587
25. K.J. Kelly, Z. Plotkin, S.L. Vulgamott, and P.C. Dagher P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor J Am Soc Nephrol 14 2003 128 138 This work shows that acute renal ischemia, which leads to GTP depletion and apoptosis of renal epithelial cells in vivo, is accompanied by mitochondrial translocation of p53 and transactivation of p53 target genes p21 and Bax. The first is reversible upon treatment with guanosine or the p53-specific inhibitor Pifithrin-α. Identical results are found with cultured renal tubular cells after GTP depletion.
26. P. Bonini, S. Cicconi, A. Cardinale, C. Vitale, A.L. Serafino, M.T. Ciotti, and L.N. Marlier Oxidative stress induces p53-mediated apoptosis in glia: p53 transcription-independent way to die J Neurosci Res 75 2004 83 95
27. C.P. Gilman, S.L. Chan, Z. Guo, X. Zhu, and N. Greig Mattson MP, p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults Neuromolecular Med 3 2003 159 172
28. M.P. Mattson Apoptosis in neurodegenerative disorders Nat Rev Mol Cell Biol 1 2000 120 129
29. M. Degli Esposti, and C. Dive Mitochondrial membrane permeabilisation by Bax/Bak Biochem Biophys Res Commun 304 2003 455 461
30. L. Scorrano, and S.J. Korsmeyer Mechanisms of cytochrome c release by proapoptotic BCL-2 family members Biochem Biophys Res Commun 304 2003 437 444
31. M. Schuler, and D.R. Green Transcription, apoptosis and p53: catch-22 Trends Genet 21 2005 182 187
32. M. Schuler, E. Bossy-Wetzel, J.C. Goldstein, P. Fitzgerald, and D.R. Green p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release J Biol Chem 275 2000 7337 7342
33. Speidel D, Helmbold H, Deppert W: Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene in press. By analysis of differently irradiated mouse fibroblasts this study provides the first in vivo evidence for transcription-independent activation of Bax by p53 and its specificity for p53-dependent apoptosis. Moreover, it is shown that an endogenous, transcription-inactive mutant p53 utilizes this mechanism and activates Bax upon DNA damage.
34. J.E. Chipuk, U. Maurer, D.R. Green, and M. Schuler Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription Cancer Cell 4 2003 371 381 Using a pharmacologically activatable p53 fusion protein, this paper demonstrates that p53-dependent and transcription-independent apoptosis proceeds via activation of Bax. This is the first report coupling a non-transcriptional pro-apoptotic activity of p53 to activation of Bax.
35. M. Li, C.L. Brooks, F. Wu-Baer, D. Chen, R. Baer, and W. Gu Mono- versus polyubiquitination: differential control of p53 fate by Mdm2 Science 302 2003 1972 1975
36. D. Michael, and M. Oren The p53-Mdm2 module and the ubiquitin system Semin Cancer Biol 13 2003 49 58
37. E. Kim, G. Rohaly, S. Heinrichs, D. Gimnopoulos, H. Meissner, and W. Deppert Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53 Oncogene 18 1999 7310 7318
38. L.T. Vassilev, B.T. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, N. Kong, U. Kammlott, C. Lukacs, and C. Klein In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 Science 303 2004 844 848 This work is the first to successfully identify potent, selective small-molecule antagonists of MDM2 as a potentially novel strategy for treating wild-type p53 cancers. The Nutlin compounds displace p53 from its binding pocket in Mdm2. This activates the p53 pathway in cancer cells, leading to cell cycle arrest, apoptosis, and inhibition of human tumor xenografts in nude mice.
39. N. Issaeva, P. Bozko, M. Enge, M. Protopopova, L.G. Verhoef, M. Masucci, A. Pramanik, and G. Selivanova Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors Nat Med 10 2004 1321 1328
40. Y. Yang, R.L. Ludwig, J.P. Jensen, S.A. Pierre, M.V. Medaglia, I.V. Davydov, Y.J. Safiran, P. Oberoi, J.H. Kenten, and A.C. Phillips Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells Cancer Cell 7 2005 547 559
41. D. Speidel, and W. Deppert p53-mediated apoptosis: a multi-faceted story K.M. Debatin S. Fulda Apoptosis and Cancer Therapy. From cutting edge science to novel therapeutic concepts 2006 Wiley-VCH